The Pharmacy Times® Pharmacy Hospital Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to hospital and health-system pharmacists.
April 22nd 2025
Thrombosis occurs in approximately 20% of myeloproliferative neoplasms.
Severe Pemphigus Vulgaris Successfully Treated With Intravenous Immunoglobulin
July 17th 2024A patient with severe and recurrent pemphigus vulgaris achieved lasting remission with a novel intravenous immunoglobulin preparation that had the added benefit of reducing treatment-related side effects.
Read More
Comparison Shows Eligibility for Vericiguat Wider Than Expected for Heart Failure
July 17th 2024Investigators compared the criteria for eligibility in the VICTORIA trial with guideline and label criterion, finding a wider than expected population with heart failure were eligible for vericiguat therapy.
Read More
Common Surgical Procedures Account for High Share of Opioid Prescriptions in Children and Adults
July 11th 2024In pediatric and adult patients, the top 3 surgical procedures accounted for the highest share of opioid prescriptions, indicating a need for better opioid prescription management and greater awareness of the possible opioid-related adverse events that can stem from prescriptions of the drug.
Read More
FTC Intends to Sue Biggest Pharmacy Benefit Managers for Unfair Negotiating Tactics
July 11th 2024In a follow-up to the interim FTC report documenting the business practices of PBMs and the power they hold in the pharmaceutical industry, the Commission now seeks to sue the 3 largest PBMs in the country for driving up the price of insulin and other essential drugs.
Read More
High-Dose Intravenous Immunoglobulin Responsive to Platelet-Activating Anti-PF4 Disorder
July 11th 2024Intravenous immunoglobulin was effective as an adjunctive treatment to anticoagulation in a patient with post-viral platelet-activating anti-PF4 disorder, indicating the need for accurate diagnosis and treatment selection.
Read More
Brexanolone and Zuranolone for the Treatment of Postpartum Depression
July 9th 2024The American College of Clinical Gynecology recommends consideration of brexanolone or zuranolone in postpartum patients with onset of moderate-to-severe perinatal depression in the third trimester or within 4 weeks postpartum.
Read More
Data-Driven Development: How Real-World Data and AI Are Transforming Clinical Trials
July 6th 2024Real-world data and artificial intelligence (AI) are poised to revolutionize drug development by optimizing clinical trials and regulatory approvals, if data quality and patient privacy challenges are addressed.
Read More
Insights on the UK's MHRA International Recognition Procedure
The UK’s Medicine and Healthcare Products Regulatory Agency (MHRA) introduced changes to streamline its drug approval processes.
Read More